{
 "dataset": "azelaic-acid-trials",
 "source": "https://verifiedbeautydata.com/ingredients/azelaic-acid/",
 "licence": "CC BY 4.0 — https://creativecommons.org/licenses/by/4.0/",
 "cite_as": "Verified Beauty Data, \"azelaic acid: trials table\", https://verifiedbeautydata.com/data/gold/azelaic-acid-trials.json",
 "row_count": 10,
 "rows": [
  {
   "trial": "Thiboutot 2003; Elewski 2003",
   "arm": "vehicle gel, study 1",
   "outcome": "Rosacea: inflammatory lesion reduction at 12 weeks, 15% gel vs vehicle (Thiboutot 2003)",
   "value_pct": 40,
   "n": 915,
   "duration_weeks": null,
   "url": "https://pubmed.ncbi.nlm.nih.gov/12789172/"
  },
  {
   "trial": "Thiboutot 2003; Elewski 2003",
   "arm": "15% azelaic acid gel, study 1",
   "outcome": "Rosacea: inflammatory lesion reduction at 12 weeks, 15% gel vs vehicle (Thiboutot 2003)",
   "value_pct": 58,
   "n": 915,
   "duration_weeks": null,
   "url": "https://pubmed.ncbi.nlm.nih.gov/12789172/"
  },
  {
   "trial": "Thiboutot 2003; Elewski 2003",
   "arm": "vehicle gel, study 2",
   "outcome": "Rosacea: inflammatory lesion reduction at 12 weeks, 15% gel vs vehicle (Thiboutot 2003)",
   "value_pct": 39,
   "n": 915,
   "duration_weeks": null,
   "url": "https://pubmed.ncbi.nlm.nih.gov/12789172/"
  },
  {
   "trial": "Thiboutot 2003; Elewski 2003",
   "arm": "15% azelaic acid gel, study 2",
   "outcome": "Rosacea: inflammatory lesion reduction at 12 weeks, 15% gel vs vehicle (Thiboutot 2003)",
   "value_pct": 51,
   "n": 915,
   "duration_weeks": null,
   "url": "https://pubmed.ncbi.nlm.nih.gov/12789172/"
  },
  {
   "trial": "Thiboutot 2003; Elewski 2003",
   "arm": "0.75% metronidazole gel",
   "outcome": "Rosacea: inflammatory lesion reduction at 15 weeks, 15% gel vs metronidazole (Elewski 2003)",
   "value_pct": 55.8,
   "n": 915,
   "duration_weeks": null,
   "url": "https://pubmed.ncbi.nlm.nih.gov/12789172/"
  },
  {
   "trial": "Thiboutot 2003; Elewski 2003",
   "arm": "15% azelaic acid gel",
   "outcome": "Rosacea: inflammatory lesion reduction at 15 weeks, 15% gel vs metronidazole (Elewski 2003)",
   "value_pct": 72.7,
   "n": 915,
   "duration_weeks": null,
   "url": "https://pubmed.ncbi.nlm.nih.gov/12789172/"
  },
  {
   "trial": "Iraji 2007 (PMID 17456913)",
   "arm": "20% azelaic acid gel",
   "outcome": "total lesion count reduction at 45 days",
   "value_pct": 60.6,
   "n": 60,
   "duration_weeks": 6,
   "url": "https://pubmed.ncbi.nlm.nih.gov/17456913/"
  },
  {
   "trial": "Thiboutot 2003, study 1 (PMID 12789172)",
   "arm": "15% azelaic acid gel",
   "outcome": "inflammatory lesion reduction vs vehicle",
   "value_pct": 58,
   "n": 329,
   "duration_weeks": 12,
   "url": "https://pubmed.ncbi.nlm.nih.gov/12789172/"
  },
  {
   "trial": "Elewski 2003 (PMID 14623704)",
   "arm": "15% azelaic acid gel",
   "outcome": "inflammatory lesion reduction",
   "value_pct": 72.7,
   "n": 251,
   "duration_weeks": 15,
   "url": "https://pubmed.ncbi.nlm.nih.gov/14623704/"
  },
  {
   "trial": "Baliña & Graupe 1991 (PMID 1816137)",
   "arm": "20% azelaic acid cream",
   "outcome": "good or excellent overall result",
   "value_pct": 65,
   "n": 329,
   "duration_weeks": 24,
   "url": "https://pubmed.ncbi.nlm.nih.gov/1816137/"
  }
 ]
}